The COVID-19 pandemic has disrupted the routine of in-person events, the need for sharing information and building key supplier connections for bio/pharmaceutical development and manufacturing has never been greater.

 The 2020 Bio/Pharma Virtual Congress event will connect bio/pharma formulation, development, manufacturing, and quality experts with a full day of technical presentations, panel discussions, interviews, and vendor meetings, through an interactive portal. 

 This online event will explore the latest developments in formulation, manufacturing, and innovative drug dosage forms, as well as detailed discussions about crucial topics impacting the industry. 

8:30 am to 4:00 pm ET

November 11, 2020

Your Computer

Four Interactive Tracks

Emerging technologies and processes that impact, enable, and advance bio/pharmaceutical development and manufacturing will be explored in Editors’ Series panel discussions and technical session presented by industry experts in four topic areas:

The COVID-19 pandemic has disrupted the routine of in-person events, the need for sharing information and building key supplier connections for bio/pharmaceutical development and manufacturing has never been greater.

 The 2020 Bio/Pharma Virtual Congress event will connect bio/pharma formulation, development, manufacturing, and quality experts with a full day of technical presentations, panel discussions, interviews, and vendor meetings, through an interactive portal. 

 This online event will explore the latest developments in formulation, manufacturing, and innovative drug dosage forms, as well as detailed discussions about crucial topics impacting the industry. 

Keynote Panel Discussions

The bio/pharma industry has demonstrated its R&D capabilities by accelerating development of vaccines and therapeutics to combat COVID-19. At the same time the industry faced intense scrutiny and political pressure. What are the short-, medium-, and long-term implications for bio/pharma development and manufacturing? Representatives of PhRMA, BIO, and other industry organizations will discuss and debate crucial business, regulatory, science-based issues facing the industry.

Supporting Sponsor:

Sponsors:

Schedule at a Glance

Wednesday, November 11th

8:30 a.m. _____________________________________________________________ 
9:00 a.m. ______________________________________________________________
9:45 a.m_________________________________________________
10:00 a.m._______________________________________________________
11:00 a.m._______________________________________________ 
11:30 a.m._______________________________________________________ 
12:30 p.m._______________________________________________ 
1:30 p.m._______________________________________________________
2:30 p.m._________________________________________________
3:00 p.m._______________________________________________________
4:00 p.m.________________________________________________________________

Registration Opens 
 Keynote Speaker
Networking Break in Exhibit Hall  
Track Breakout Sessions 
Networking Break in Exhibit Hall 
Track Breakout Sessions 
Networking Break in Exhibit Hall 
Track Breakout Sessions
Networking Break in Exhibit Hall
Track Breakout Sessions 
Event Close

November 11, 2020

8:30 am to 4:00 pm ET

Your Computer

Featured Speakers

FORMULATION

Topics included in this session are drug development, drug delivery, APIs, excipients, formulation trends, modified release, injectable drug formulation, and more.

MANUFACTURING

Topics included in this session are manufacturing strategies, process analytical technology, process and operational intelligence, data integrity, predictive maintenance, scale up, 
fluid-bed coating, and more

DRUG DOSAGE FORM TRENDS

Topics include in this session are vaccines, biologics, solid dosage drugs, controlled release, cell and gene therapies, and more.

BIOPHARMA INDUSTRY CHALLENGES

Topics included in this sessions are drug quality, regulatory inspections, COVID-19 pandemic impact, good manufacturing practices, regulated documents, and more

Keynote Panel Discussion

The bio/pharma industry has demonstrated its R&D capabilities by accelerating development of vaccines and therapeutics to combat COVID-19. At the same time the industry faced intense scrutiny and political pressure. What are the short-, medium-, and long-term implications for bio/pharma development and manufacturing? Representatives of PhRMA, BIO, and other industry organizations will discuss and debate crucial business, regulatory, science-based issues facing the industry.